CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-04 | Lamond David Director | Purchase | +15,969 | $36.34 | $580K | 1,793,009 |
| 2021-03-04 | Lamond David Director | Purchase | +4,100 | $36.86 | $151K | 1,797,109 |
| 2021-02-09 | Monohon Ted Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-02-09 | LOWE CHRISTOPHER P. COO & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −400 | $37.39 | $15K | 1,058,374 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −1,600 | $38.64 | $62K | 1,056,774 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −856 | $39.82 | $34K | 1,055,918 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −2,000 | $40.84 | $82K | 1,053,918 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −3,100 | $41.91 | $130K | 1,050,818 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −1,512 | $43.10 | $65K | 1,049,306 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −1,900 | $44.22 | $84K | 1,047,406 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −8,032 | $45.00 | $361K | 1,039,374 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −600 | $45.73 | $27K | 1,038,774 |
| 2021-02-02 | Lynch Casey Chief Executive Officer | Sale | −14,929 | $36.02 | $538K | 1,063,845 |
| 2021-02-02 | Lynch Casey Chief Executive Officer | Sale | −5,071 | $36.75 | $186K | 1,058,774 |
| 2021-02-01 | Lynch Casey Chief Executive Officer | Sale | −4,686 | $34.60 | $162K | 1,094,088 |
| 2021-02-01 | Lynch Casey Chief Executive Officer | Sale | −3,100 | $35.59 | $110K | 1,090,988 |
| 2021-02-01 | Lynch Casey Chief Executive Officer | Sale | −7,460 | $36.56 | $273K | 1,083,528 |
| 2021-02-01 | Lynch Casey Chief Executive Officer | Sale | −4,283 | $37.68 | $161K | 1,079,245 |
| 2021-02-01 | Lynch Casey Chief Executive Officer | Sale | −100 | $38.28 | $4K | 1,079,145 |
Page 12 of 18 · 350 trades